Rational design of 1,2,3-triazole hybrid structures as novel anticancer agents: synthesis, biological evaluation and molecular docking studies

Abstract

New hybrid compounds belonging to the class of 1,4-disubstituted 1,2,3-triazoles were synthesized. The structural characterization of the synthesized compounds was performed using IR, ¹H-NMR, ¹³C NMR and elemental analysis techniques. Diarylketones <b>1a</b> and <b>1b</b> were used as starting compounds for the synthesis of triazoles. The corresponding diarylmethanol derivatives (<b>2a,b</b>) were obtained from reduction of ketone units with NaBH₄. Oxyalkynes (<b>3a,b</b>) were obtained by treating the hydroxyl group with NaH in anhydrous THF and then with propargylbromide. The target hybrid structures <b>6a-n</b> were obtained from the metal-catalyzed "click reaction" of the arylazide and alkyne units. The newly synthesized compounds were structurally analysed using ¹H-NMR, ¹³C-NMR, elemental analysis, LC-MS and FT-IR. The antioxidant and anticancer activities of all compounds were investigated. It has been determined that the new hybrid structures have very good antioxidant and anticancer activities according to the standards. In particular, compounds <b>6b, 6h, 6i</b> and <b>6j</b> (IC₅₀: 1.87, 12.5, 7.22, 8.04 µM) showed excellent activity compared to standard <b>5-Fu</b> (IC₅₀: 40.89 µM). According to the results of molecular docking of compounds <b>6b</b> and <b>6i</b> with the highest cancer activity, MetAP-2 was found to have a high affinity through exposed polar and apolar contacts with fundemental residues in the binding pocket.Communicated by Ramaswamy H. Sarma.